or
forgot password
  • cancer clinical trials in jackson, MS

  • Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Leukemia
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Veterans Affairs Medical Center - Jackson
    Jackson, Mississippi 39216
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Leukemia, Lymphoma
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Veterans Affairs Medical Center - Jackson

    Trial Locations
    Veterans Affairs Medical Center - Jackson
    University of Mississippi Cancer Clinic
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Leukemia, Lymphoma
    Collecting Tumor Samples From Patients With Gynecological Tumors
    University of Mississippi Cancer Clinic

    Trial Locations
    University of Mississippi Cancer Clinic
    St. Dominic Cancer Center
    Cancer
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Lymphoma
    S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Neuroblastoma
    Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
    University of Mississippi
    Jackson, Mississippi 39216
    Head and Neck Squamous Cell Carcinoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Veterans Affairs Medical Center - Jackson

    Trial Locations
    Veterans Affairs Medical Center - Jackson
    University of Mississippi Cancer Clinic
    Lung Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Lung Cancer
    Stem Cell Related Donor Safety Study
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Related Hematopoietic Stem Cell Donors
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Ovarian Cancer, Sarcoma
    Study of Blood Samples From Newborns With Down Syndrome
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Leukemia
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Saint Dominic-Jackson Memorial Hospital
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Lymphoma, Lymphoproliferative Disorder
    Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Survey of Inhibitors in Plasma-Product Exposed Toddlers
    Univ of Mississippi Medical Center, Pediatric Hematology/Oncology
    Jackson, Mississippi 39216
    Hemophilia A
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    St. Dominic Cancer Center
    Jackson, Mississippi 39216
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    Jackson Oncology Associates
    Jackson, Mississippi 39202
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Breast Cancer
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Cervical Cancer
    Everolimus Versus Placebo in Head and Neck Cancer
    University of Mississippi
    Jackson, Mississippi 39216
    Head and Neck Cancer
    EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Breast Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Leukemia
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Saint Dominic-Jackson Memorial Hospital
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Sickle Cell Anemia, Sickle ß0-Thalassemia